Natera, Inc. (NTRA)
NASDAQ: NTRA · Real-Time Price · USD
175.43
+0.42 (0.24%)
At close: Sep 17, 2025, 4:00 PM EDT
176.10
+0.67 (0.38%)
After-hours: Sep 17, 2025, 7:37 PM EDT
Natera Market Cap
Natera has a market cap or net worth of $24.08 billion as of September 17, 2025. Its market cap has increased by 67.46% in one year.
Market Cap
24.08B
Enterprise Value
23.26B
1-Year Change
67.46%
Ranking
Category
Stock Price
$175.43
Market Cap Chart
Since July 2, 2015, Natera's market cap has increased from $1.10B to $24.08B, an increase of 2,086.47%. That is a compound annual growth rate of 35.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 24.02B | 14.93% |
| Dec 31, 2024 | 20.90B | 177.68% |
| Dec 29, 2023 | 7.53B | 91.96% |
| Dec 30, 2022 | 3.92B | -55.62% |
| Dec 31, 2021 | 8.83B | 3.98% |
| Dec 31, 2020 | 8.50B | 225.28% |
| Dec 31, 2019 | 2.61B | 202.62% |
| Dec 31, 2018 | 863.10M | 78.55% |
| Dec 29, 2017 | 483.40M | -21.19% |
| Dec 30, 2016 | 613.40M | 13.59% |
| Dec 31, 2015 | 540.00M | -50.96% |
| Jul 2, 2015 | 1.10B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |